Should You Buy Regeneron Pharmaceuticals Stock Before Oct. 30?
The healthcare company will release its third-quarter results next month.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
What's breaking now, across thousands of outlets.
The healthcare company will release its third-quarter results next month.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
Key PointsBoth companies have impressive dividend histories.
This is not a left/right issue.
The City of London is lobbying hard against the prospect of a windfall tax on the banks ahead of the October budget.
An airstrike carried out by Myanmar's military near a market in territory controlled by a powerful rebel group killed at least 33 people and wounded 36 others on Monday, the group and a rescue…
But outflows matched investments last week, with US investors choosing to exit
More important than the frequency is the dividend yield -- and that was recently a fat 5.9%.